abstract |
The present invention relates to optionally pharmaceutically acceptable salts, solvates, polymorphs, prodrugs, tautomers, racemates, enantiomers or diastereomers useful for the treatment, amelioration or prevention of viral diseases. Or a compound having the following general formula I in the form of a mixture thereof: In addition, specific combination therapies are disclosed. [Chemical 1] [Selection figure] None |